Primary Hyperoxaluria Type 3 (PH3)
·MeSH: Hyperoxaluria, Primary
Prevalence
0.1 / 100K
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Primary Hyperoxaluria Type 3 (PH3)?
There are 1 clinical trial targeting Primary Hyperoxaluria Type 3 (PH3) tracked by BioSniper.
What is the prevalence of Primary Hyperoxaluria Type 3 (PH3)?
The estimated prevalence of Primary Hyperoxaluria Type 3 (PH3) is approximately 0.1 per 100,000 population.
Deep-dive into Primary Hyperoxaluria Type 3 (PH3)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis